Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.950
+0.020 (0.68%)
May 28, 2026, 12:57 PM EDT - Market open
Spero Therapeutics Employees
Spero Therapeutics had 25 employees as of December 31, 2025. The number of employees decreased by 7 or -21.88% compared to the previous year.
Employees
25
Change (1Y)
-7
Growth (1Y)
-21.88%
Revenue / Employee
$2,447,440
Profits / Employee
$609,400
Market Cap
170.81M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 25 | -7 | -21.88% |
| Dec 31, 2024 | 32 | -14 | -30.43% |
| Dec 31, 2023 | 46 | 11 | 31.43% |
| Dec 31, 2022 | 35 | -111 | -76.03% |
| Dec 31, 2021 | 146 | 57 | 64.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Heron Therapeutics | 128 |
| Tenaya Therapeutics | 70 |
| Korro Bio | 49 |
| TuHURA Biosciences | 22 |
| Galectin Therapeutics | 9 |
| Kazia Therapeutics | 6 |
SPRO News
- 14 days ago - Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update - GlobeNewsWire
- 14 days ago - Spero Therapeutics Earnings release: Q1 2026 - Filings
- 14 days ago - Spero Therapeutics Quarterly report: Q1 2026 - Filings
- 22 days ago - Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 - GlobeNewsWire
- 4 weeks ago - Spero Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Spero Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Spero Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update - GlobeNewsWire